A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : t-AML

Search Conditions:
Search Keyword : t-AML
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: t-AML
Appearance Frequency: 205 time(s)
Long forms: 15

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
therapy-related acute myeloid leukemia
(148 times)
Neoplasms
(65 times)
t-MDS (25 times)
OS (13 times)
APL (11 times)
1990 Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
therapy-related AML
(37 times)
Hematology
(24 times)
AML (29 times)
MDS (9 times)
CR (5 times)
1993 Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
therapy related leukemia
(4 times)
Neoplasms
(3 times)
ALL (2 times)
AML (2 times)
BCRs (1 time)
1997 Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
treatment-related AML
(3 times)
Neoplasms
(1 time)
AML (2 times)
ALL (1 time)
AML-MDS (1 time)
1998 Secondary leukemias induced by topoisomerase-targeted drugs.
treatment-related leukemia
(2 times)
Genetics, Medical
(1 time)
bcr (1 time)
GAA (1 time)
TMZ (1 time)
2003 Polymorphisms in the MLL breakpoint cluster region (BCR).
treatment-related myelodysplasia/leukemia
(2 times)
Neoplasms
(2 times)
MSKCC (1 time)
1998 High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
MDS-transformed acute myeloid leukemia
(1 time)
Hematology
(1 time)
CR (1 time)
DA (1 time)
G-CSF (1 time)
2009 Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
t-acute myeloid leukemia
(1 time)
Hematology
(1 time)
allo-HCT (1 time)
CR (1 time)
OS (1 time)
2018 Nationwide survey of therapy-related leukemia in childhood in Japan.
therapy AML
(1 time)
Hematology
(1 time)
ALL (1 time)
AML (1 time)
bcr (1 time)
1998 An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
10  Therapy-related acute leukemia
(1 time)
Medicine
(1 time)
CNA (1 time)
MCRs (1 time)
p-AML (1 time)
2011 Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
11  therapy-related acute myeloid
(1 time)
Hematology
(1 time)
ASCT (1 time)
2011 An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant.
12  therapy-related forms
(1 time)
Neoplasms
(1 time)
AML (1 time)
2006 Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia.
13  Therapy-related, secondary acute myeloid leukemia
(1 time)
Genetics, Medical
(1 time)
ChIP-seq (1 time)
PGNet (1 time)
Sema3A (1 time)
2015 Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.
14  treatment-related acute granulocyte-monocytic leukemia
(1 time)
Medicine
(1 time)
MM (1 time)
2017 Treatment-related acute granulocyte-monocytic leukemia from multiple myeloma: A case report and literature review.
15  Typically, secondary acute myeloid leukemia
(1 time)
Toxicology
(1 time)
topo II (1 time)
1999 Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?